Research programme: metabolite replacement therapeutics - TM3 Therapeutics

Drug Profile

Research programme: metabolite replacement therapeutics - TM3 Therapeutics

Alternative Names: Acetyl-4’-phosphopantetheine; P-PantSAc; TM-1803

Latest Information Update: 18 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator TIRCON
  • Developer TIRCON; TM3 Therapeutics; University Medical Center Groningen
  • Class Neuroprotectants
  • Mechanism of Action Phosphopantothenate replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pantothenate kinase-associated neurodegeneration
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Pantothenate kinase-associated neurodegeneration

Most Recent Events

  • 13 Sep 2017 Preclinical trials in Pantothenate kinase-associated neurodegeneration in Netherlands and USA (unspecified route)
  • 13 Sep 2017 Research programme: metabolite replacement therapeutics - TM3 Therapeutics receives Orphan Drug status for Pantothenate kinase-associated neurodegeneration in European Union
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top